Journal
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
Volume 137, Issue -, Pages -Publisher
ELSEVIER
DOI: 10.1016/j.ejps.2019.104967
Keywords
Poorly water-soluble drugs; Formulation; Bioavailability; Drug delivery; Lipid formulations; Solid state
Categories
Funding
- COST (European Cooperation in Science and Technology) [CA16205]
Ask authors/readers for more resources
Poorly water-soluble drugs continue to be a problematic, yet important class of pharmaceutical compounds for treatment of a wide range of diseases. Their prevalence in discovery is still high, and their development is usually limited by our lack of a complete understanding of how the complex chemical, physiological and biochemical processes that occur between administration and absorption individually and together impact on bioavailability. This review defines the challenge presented by these drugs, outlines contemporary strategies to solve this challenge, and consequent in silico and in vitro evaluation of the delivery technologies for poorly water-soluble drugs. The next steps and unmet needs are proposed to present a roadmap for future studies for the field to consider enabling progress in delivery of poorly water-soluble compounds.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available